Myelodysplastic syndromes: Challenges to improving patient and caregiver satisfaction

American Journal of Medicine

Volumn 125, Issue 7 SUPPL., 2012, Pages

  Smith, B Douglas ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Caregiver satisfaction; Myelodysplastic syndromes; Patient satisfaction

Indexed keywords

AGED; ARTICLE; AWARENESS; CAREGIVER; DISEASE SEVERITY; FEMALE; GOAL ATTAINMENT; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PATIENT CARE; PATIENT SATISFACTION; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

AGED; CAREGIVERS; FEMALE; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; PATIENT SATISFACTION; PERSONAL SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PROGNOSIS;

EID: 84862840448     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.04.020     Document Type: Article

References (23)

1. J.M. Bennett, D. Catovsky, M.T. Daniel Proposals for the classification of the myelodysplastic syndromes Br J Haematol 51 1982 189 199
2. D. Haase, U. Germing, J. Schanz New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients Blood 110 2007 4385 4395
3. J.W. Vardiman, N.L. Harris, R.D. Brunning The World Health Organization (WHO) classification of the myeloid neoplasms Blood 100 2002 2292 2302
4. A.B. Kornblith, I.I. Herndon JE, L.R. Silverman Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study J Clin Oncol 20 2002 2441 2452
5. L.R. Silverman, E.P. Demakos, B.L. Peterson Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B J Clin Oncol 20 2002 2429 2440
6. H. Kantarjian, J.P. Issa, C.S. Rosenfeld Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study Cancer 106 2006 1794 1803
7. P. Fenaux, G.J. Mufti, E. Hellstrom-Lindberg Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study Lancet Oncol 10 2009 223 232
8. P. Fenaux, A. Giagounidis, D. Selleslag A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q Blood 118 2011 3765 3776
9. M.A. Sekeres, W.M. Schoonen, H. Kantarjian Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys J Natl Cancer Inst 100 2008 1542 1551
10. P. Greenberg, C. Cox, M.M. LeBeau International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 1997 2079 2088
11. J.W. Vardiman, J. Thiele, D.A. Arber The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Blood 114 2009 937 951
12. G. Leone, L. Pagano, D. Ben-Yehuda, M.T. Voso Therapy-related leukemia and myelodysplasia: susceptibility and incidence Haematologica 92 2007 1389 1398
13. B.L. Scott, H.J. Deeg Myelodysplastic syndromes Annu Rev Med 61 2010 345 358
14. M.A. Sekeres, J.P. Maciejewski, A.F. List Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an Internet-based survey Oncologist 16 2011 904 911
15. C. Aul, N. Gattermann, W. Schneider Age-related incidence and other epidemiological aspects of myelodysplastic syndromes Br J Haematol 82 1992 358 367
16. S.A. Adebonojo, A.N. Bowser, D.M. Moritz, P.C. Corcoran Impact of revised stage classification of lung cancer on survival: a military experience Chest 115 1999 1507 1513
17. B. Deschler, T. de Witte, R. Mertelsmann, M. Lübbert Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches Haematologica 91 2006 1513 1522
18. L. Malcovati, U. Germing, A. Kuendgen Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes J Clin Oncol 25 2007 3503 3510
19. G. Garcia-Manero, J. Shan, S. Faderl A prognostic score for patients with lower risk myelodysplastic syndrome Leukemia 22 2008 538 543
20. H. Kantarjian, S. O'Brien, F. Ravandi Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System Cancer 113 2008 1351 1361
21. E. Such, J. Cervera, B. Nomdedeu A new prognostic scoring system including transfusion dependency and cytogenetic abnormalities for patients with chronic myelomonocytic leukemia Blood 114 2009 Abstract 1750
22. H. Kim, E. Jabbour, T. Kadia A prognostic model of therapy-related myelodysplastic syndrome Blood 114 2009 Abstract 3796
23. National Comprehensive Cancer Network (NCCN) (2011).NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Myelodysplastic syndromes Version 2.2011 http://www.nccn.org/professionals/physician-gls/pdf/mds.pdf 2011 Accessed June 8, 2011